Skip to content
LexBuild

Disease, Disability, and Injury Prevention and Control

---
identifier: "/us/fr/05-11878"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Disease, Disability, and Injury Prevention and Control"
title_number: 0
title_name: "Federal Register"
section_number: "05-11878"
section_name: "Disease, Disability, and Injury Prevention and Control"
positive_law: false
currency: "2005-06-16"
last_updated: "2005-06-16"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "05-11878"
document_type: "notice"
publication_date: "2005-06-16"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "70 FR 35086"
fr_volume: 70
---

#  Disease, Disability, and Injury Prevention and Control

Special Emphasis Panel (SEP): Health Promotion and Disease Prevention Research Centers: Special Interest Project Competitive Supplements, Program Announcement Number (PA) DP-04-003A

In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting:

*Name:* Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Health Promotion and Disease Prevention Research Centers: Special Interest Project Competitive Supplements, Program Announcement Number (PA) DP-04-003A.

*Times and Dates:* 2 p.m.-5 p.m., July 11, 2005(Closed); 8:30 a.m.-5 p.m., July 12, 2005(Closed); 8:30 a.m.-5 p.m., July 13, 2005(Closed); 8:30 a.m.-5 p.m., July 14, 2005(Closed).

*Place:* Sheraton Colony Square Hotel, 188 14th Street, Atlanta, GA. 30361, Telephone Number 1.800.276.7415.

*Status:* The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director,  Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

*Matters to be Discussed:* The meeting will include the review, discussion, and evaluation of applications received in response to: Health Promotion and Disease Prevention Research Centers: Special Interest Project Competitive Supplements, Program Announcement Number (PA) DP-04-003A.

*Contact Person for More Information:* Gwendolyn H. Cattledge, Ph.D., MSEP, Scientific Review Administrator, National Center for Chronic Disease Prevention and Health Promotion, CDC, 4770 Buford Highway, NE, Mailstop K-02, Atlanta, GA 30341, Telephone (770) 488-4655.

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: June 8, 2005.

Alvin Hall,

Director, Management Analysis and Services Office, , Centers for Disease Control and Prevention.